Intensity logo
Intensity Logo
Hanita Lenses logo white

Vision Redefined

Real World Results

Goal: To measure the visual acuity of real-life patients with the lens across all distances, as well as their overall satisfaction with the results.

Intensity

Our study

This multicenter study includes both retrospective and prospective components, and is a single-arm, open-label investigation aimed at evaluating the performance of the INTENSITY IOL.

The combined data set includes findings from multiple centers to provide a comprehensive evaluation of the Intensity intraocular lens across diverse patient populations and clinical settings. 

+1.3K Eyes

Population

The research population consists of patients diagnosed with cataracts who require surgery and are suitable candidates for multifocal intraocular lenses (IOLs). These patients are motivated to receive multifocal IOLs and have no retinal or optic nerve abnormalities. 

Performance

Defocus curve

Defocus curve
Defocus (D)

Efficacy

Visual acuity

Surgery

How it works

Satisfaction

What our patients say

Visual Function Questionnaire VF14
Comparison with modern trifocal IOL
Visual Phenomena

Comparison

Lenses Energy Utilization %

Lenses Energy Utilization %
Comparison

Conclusions

Highlights

The Intensity lens significantly enhances quality of life by delivering exceptional vision at all distances, proven in real-world settings.

innovative design

Clinical results confirm innovative design ensures spectacle independence for pseudophakic patients, delivering superior vision at all distances.

average visual acuity

Achieves an average visual acuity better than 6/6.7 from infinity to 40 cm, providing sharp vision across all distances.

High patient satisfaction, making Intensity the ideal choice for those seeking enhanced everyday visual performance.

Contact us

To receive more information or schedule a private session please leave your details.

1. Bellucci et al., 2024. Comparison of Objective and Subjective Visual Outcomes Between Pentafocal and Trifocal Diffractive Intraocular Lenses. Journal of Refractive Surgery, 40(9), e604-e613. 2. Nov et al., 2022. Visual performance of a novel optical design of a new multifocal intraocular lens. Journal of Refractive Surgery, 38(3), 150-157. 3. Data on File, DHF102, Hanita Lenses 4. Kohnen et al. Visual performance of a quadrifocal (trifocal) intraocular lens following removal of the crystalline lens. Am J Ophthalmol. 2017;184:52-62. 5. Sudhir et al. AcrySof IQ PanOptix intraocular lens versus extended depth of focus intraocular lens and trifocal intraocular lens: a clinical overview. Asia Pac J Ophthalmol (Phila). 2019;8(4):335-349. 6. Gatinel et al. Design and qualification of a diffractive trifocal optical profile for intraocular lenses. J Cataract Refract Surg. 2011;37(11):2060-2067. 7. Carballo-Alvarez et al. Visual outcomes after bilateral trifocal diffractive intraocular lens implantation. BMC Ophthalmology. 2015;15:26 8. Assia, E. (2024, September 6–10). Real world outcomes of Intensity IOL [Conference presentation]. 42nd congress of the ESCRS, Barcelona, Spain. 9. Goldman, G. (2024). Clinical results with a multifocal intraocular lens with a novel optical design. BMC ophthalmology, 24(1), 269. 10. Alió et al., 2024. Clinical outcomes with a new diffractive multifocal intraocular lens optimized by the dynamic light utilization algorithm. Eye, 1-7. 11. Bianchi, G. R. (2022). A prospective study of a new presbyopia pseudophakic intraocular lens: Safety, efficacy and satisfaction. Indian Journal of Ophthalmology, 70(9), 3305-3310. 12. Balparda et al., 2024. Short-Term Visual Outcomes After Bilateral Pentafocal Intraocular Lens Implantation. A Pilot Study. Highlights of Ophthalmology, 52(4ENG), 29-36. 13. Agarwal, A. Assessing the Visual Performance of Hanita Lenses “Intensity SL” Intraocular Lens 2022. Clinical study. Data on file, DHF102, Hanita Lenses.  14. Knyazer, B. (2022) Clinical experience with Intensity SL and Intensity Toric Multiufocal IOLs. Annual meeting of the Israeli Ophthalmological Society, IOS 2022.